Paper Details

  1. Home
  2. Paper Details

[Comparison of therapeutic effect of different doses of ganciclovir for neonatal congenital cytomegalovirus infection].

Author: BoTao, ChenPing-Yang, GeJian-Fang, HeXiao-Ri, HuJin-Tao, WangTao, XieZong-De

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study compared the efficacy and side effects of relatively low and high doses of ganciclovir in the treatment of neonatal congenital cytomegalovirus (CMV) infection.
Paper Details　
Original Abstract of the Article :
Ganciclovir is a first-line drug for treatment of cytomegalovirus (CMV) infection. However, some ganciclovir treatment-related side-effects can be found. This study aimed to compare the efficacy and side effects of relatively low and high doses of ganciclovir in the treatment of neonatal congenital ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/19695189

データ提供：米国国立医学図書館（NLM）

Exploring the Efficacy of Ganciclovir in Treating Neonatal Congenital Cytomegalovirus Infection

The research delves into the world of cytomegalovirus (CMV) infection, a common viral infection that can affect newborns. It's like exploring a vast desert where CMV poses a threat to the health of young travelers. The study focuses on ganciclovir, a medication used to treat CMV infection, investigating its effectiveness in treating neonatal congenital CMV infection. It's like finding a potential oasis in the desert, a treatment that might offer relief and support for newborns facing CMV infection.

The researchers conducted a study comparing the efficacy and side effects of different doses of ganciclovir in treating neonatal congenital CMV infection. It's like carefully navigating a desert landscape, adjusting the dosage of a precious resource (ganciclovir) to ensure its effectiveness and safety for young travelers.

The study aimed to determine the optimal dose of ganciclovir for treating neonatal congenital CMV infection, seeking a balance between effectiveness and minimizing potential side effects. It's like finding the right amount of water needed to sustain life in the desert, ensuring both hydration and safety.

Finding the Right Dosage for a Smoother Journey

This research explores the efficacy of ganciclovir in treating neonatal congenital cytomegalovirus infection, seeking the optimal dose to maximize benefits and minimize potential side effects. It's like navigating a desert landscape, finding the right balance of resources to ensure a successful and safe journey for young travelers.

A Guiding Light in the Desert of CMV Infection

The study provides valuable insights into the treatment of neonatal congenital cytomegalovirus (CMV) infection. It's like finding a guiding light in the desert of CMV infection, providing a beacon of hope for families facing this challenge. The research helps identify the optimal dose of ganciclovir for treating CMV infection, potentially leading to improved outcomes for newborns facing this condition.

Dr.Camel's Conclusion

This research helps illuminate the path for treating neonatal congenital cytomegalovirus infection, seeking the optimal dose of ganciclovir to ensure the best possible outcome for young travelers through the desert of illness.

Date :
  1. Date Completed 2010-04-05
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

19695189

DOI: Digital Object Identifier

1008-8830(2009)08-0641-04

SNS
PICO Info
in preparation
Languages

Chinese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.